CTI BioPharma
CTIC
#5126
Rank
HK$9.29 B
Marketcap
HK$70.51
Share price
0.00%
Change (1 day)
29.59%
Change (1 year)

EPS for CTI BioPharma (CTIC)

EPS in 2023 (TTM): -HK$4.55

According to CTI BioPharma 's latest financial reports the company's current EPS (TTM) is -HK$4.50. In 2022 the company made an earnings per share (EPS) of -HK$6.59 an increase over its 2021 EPS that were of -HK$8.38.

EPS history for CTI BioPharma from 2014 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-HK$4.55-31.03%
2022-HK$6.59-21.3%
2021-HK$8.3845.95%
2020-HK$5.747.25%
2019-HK$5.3530.19%
2018-HK$4.11-58.91%
2017-HK$10.01-29.12%
2016-HK$14.12-72.84%
2015-HK$51.976.35%
2014-HK$48.87

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
HK$109.75-2,539.66%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$30.79-784.48%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$14.74-427.59%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$39.71-982.76%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$42.11-1,036.08%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$15.51 244.83%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
HK$29.01-744.83%๐Ÿ‡จ๐Ÿ‡ญ Switzerland